Insurance coverage
Does TRICARE cover Wegovy, Zepbound, Ozempic, and compounded GLP-1s? What prior authorization looks like, and what to do if you're denied.
| Medication | Coverage |
|---|---|
| Wegovy (semaglutide for weight loss) | Yes (with prior auth, BMI criteria) |
| Zepbound (tirzepatide for weight loss) | Yes (with prior auth) |
| Ozempic (semaglutide for diabetes) | Yes for Type 2 diabetes |
| Compounded sema/tirz | No |
TRICARE covers Wegovy and Zepbound for active duty, retirees, and dependents who meet BMI and comorbidity criteria. Express Scripts is the TRICARE pharmacy benefit administrator.
Use the TRICARE Formulary Search Tool to confirm tier and prior auth. Compounded GLP-1s are not covered.
Your prescribing clinician's office handles the prior authorization submission. Approval timelines vary from 24 hours to 2 weeks depending on the carrier.
If your prior authorization is denied or your plan excludes weight-loss drugs, you have three primary options:
NexLife is our 2026 editor's pick. $199/mo flat-rate compounded semaglutide, physician-led under Dr. Adam Kennah, MD, LegitScript certified.
Visit NexLife →Yes (with prior auth, BMI criteria)
Yes (with prior auth)
Yes for Type 2 diabetes (Ozempic is FDA-approved for Type 2 diabetes; off-label use for weight loss is generally not covered).
No. No major commercial payer covers compounded GLP-1 medications. Compounded prescriptions are paid out-of-pocket.
Most plans require: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (Type 2 diabetes, hypertension, dyslipidemia, sleep apnea); documented prior weight-loss attempts; ongoing clinical follow-up. Your prescriber's office handles the prior auth submission.
If your plan denies, options include: (1) appeal with additional clinical documentation; (2) compounded GLP-1s through telehealth ($199–$499/month); (3) manufacturer copay programs (limited). See our compounded vs brand-name guide.